Results 251 to 260 of about 2,763,581 (350)

Efficacy and Safety of Anti‐IL‐4Rα Stapokibart in Elderly Patients With Moderate‐To‐Severe Atopic Dermatitis

International Journal of Dermatology, EarlyView.
ABSTRACT Background Elderly patients with moderate‐to‐severe atopic dermatitis (AD) often exhibit more heterogeneous inflammatory profiles compared with younger adults. To evaluate the efficacy and safety of stapokibart, an anti‐interleukin‐4 receptor α subunit (IL‐4Rα) monoclonal antibody, in different age subgroups.
Yan Zhao, Litao Zhang, Liming Wu, Bin Yang, Jinyan Wang, Yumei Li, Qingchun Diao, Jingyi Li, Qing Sun, Xiaohong Zhu, Xiaoyong Man, Lihua Wang, Yanyan Feng, Tao Cai, Huiming Zeng, Linfeng Li, Jianyun Lu, Hong Ren, Fuqiu Li, Qianjin Lu, Xiaohua Tao, Rong Xiao, Chao Ji, Jing Sun, Yanping Qiu, Bo Chen, Jianzhong Zhang   +26 more
wiley   +1 more source

Resolution of Chronic Urticaria in a Vegan Patient With Vitamin B12 Supplementation: A Case Report. [PDF]

J Community Hosp Intern Med Perspect
Auda AH, Shoewu O, Corredor I, Bangolo A, Jurri M, Sotiriadis J, Baker I.   +6 more
europepmc   +1 more source

Pathogenesis and Therapeutics for Chronic Pruritus of Unknown Origin: A Systematic Review

International Journal of Dermatology, EarlyView.
ABSTRACT Chronic pruritus of unknown origin (CPUO) is a distressing condition characterized by persistent itch lasting over 6 weeks without an identifiable cause. The underlying mechanisms remain poorly understood, complicating diagnosis and treatment.
Yagiz Matthew Akiska, Isha Gandhi, Robert Adler, Deena Fayyad, Perya Bhagchandani, Shabnam Afzal, Waleed Adawi, Shivani Patel, Shawn G. Kwatra   +8 more
wiley   +1 more source

Translation and Validation of Urticaria Control Test (UCT) and Chronic Urticaria Quality of Life (CU-Q2oL) Questionnaires in Hindi.

Indian J Dermatol
De A, Ahmed SKS, Datta S, Mukherjee M, Singh S, Kumari P, Sarda A, Godse K.   +7 more
europepmc   +1 more source

Dermatologists' knowledge, attitudes, and practices regarding omalizumab therapy for chronic urticaria. [PDF]

Arch Dermatol Res
Wu S, Ye X, Liu X, Dai L, Chen H.
europepmc   +1 more source

Epidemiology and Genetics of Rheumatic Diseases Suggest a Constant Rate of DNA Damage as Underlying Cause

Immunology, EarlyView.
A constant rate of DNA damage that is not perfectly repaired will cause a constant rate of DNA mutations. The chance of mutation will increase if DNA is prone to damage, such as occurs in somatic hypermutation (SHM) hotspots and GC‐rich DNA. Thus, if one mutation‐prone DNA site drives disease, the age of onset of disease and degree of penetrance should
Piet C. de Groen
wiley   +1 more source

Sleep Disturbance Mediates the Association Between Disease Activity and Work Productivity Impairments in Chronic Urticaria. [PDF]

Allergy
Mak HWF, Lee E, Wong JCY, Li PH.
europepmc   +1 more source

Acceptance and perceived usefulness of digital health services in the management of chronic urticaria: a survey of patients and physicians. [PDF]

BMC Health Serv Res
Hindelang M, Zink A, Knitza J, Darkow R, Welcker M, Biedermann T, May S, Muehlensiepen F.   +7 more
europepmc   +1 more source

Long‐term safety and efficacy of secukinumab in paediatric severe plaque psoriasis: 236‐week, Phase 3 trial results

Journal of the European Academy of Dermatology and Venereology, EarlyView.
In this Phase III study, secukinumab demonstrated sustained efficacy and a favourable safety profile in paediatric patients with chronic severe plaque psoriasis over a treatment period of 236 weeks. Abstract Background Plaque psoriasis, a chronic inflammatory disease, affects up to 2.1% of the global paediatric population.
Andrzej Kaszuba, Philemon Papanastasiou, Dorota Krasowska, Raul De Lucas Laguna, Michael Ziv, Shoba Ravichandran, Amita Bansal, Swapnil S. Dahale, Ruvie Martin, Bertrand Paguet, Nina Magnolo, Kulli Kingo   +11 more
wiley   +1 more source

Sexual Dysfunction in Chronic Urticaria: A Systematic Review. [PDF]

Dermatol Ther (Heidelb)
Park SE, Ma E, Dagenet C, Aleshin MA, Holahan HM, Shi VY, Hsiao JL.   +6 more
europepmc   +1 more source